One hypothesis of the cycle of anhedonia (loss of interest or pleasure) in patients with depression is illustrated in this image; this hypothesis comes from a series of experiments performed on a sample of psychology students.1 The students were given the Beck Depression Inventory (BDI), and only those who displayed either high (BDI score >20) or low (<10) depressive symptomatology were included in the study.1 As well as completing a series of questionnaires, their helping behaviour was tested during the debriefing process when, in what was made to seem like an accident, a researcher dropped a pile of papers near the participant – latency to help, and the degree of help provided was used as a proxy for helping behaviour, and social anhedonia.1 Higher levels of participants not helping were seen in the high depressive symptomatology group.1

There have been attempts to assay the effectiveness of newer antidepressants against the symptoms of anhedonia; one such study found that treatment over eight weeks with a melatonin receptor agonist decreased severity scores on depression scales, as well as scores on the Snaith-Hamilton Pleasure Scale that measures anhedonia.3 However, effectiveness on symptoms of anhedonia remains an unmet need in the treatment of MDD.1,2,3

MDD=major depressive disorder

file_download Download in HQ

Related content

image Image
Childhood trauma and antidepressant response
31.07.2025 Depression
image Image
The tolerability and safety profile of dopamine–serotonin receptor antagonists

As adjunctive treatment in MDD, some dopamine–serotonin receptor antagonists are associated with sedating side effects, while others are more often associated with ‘activating’ side effects.

29.07.2025 Depression
image Image
Basic mechanisms of antidepressant action

In general, antidepressants function by increasing the availability of monoamines in the synapse; these monoamines are thought to be depleted in depression.

29.07.2025 Depression